BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
304 hedge funds and large institutions have $7.15B invested in Blueprint Medicines in 2024 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 114 increasing their positions, 100 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
14% more repeat investments, than reductions
Existing positions increased: 114 | Existing positions reduced: 100
8% more funds holding
Funds holding: 282 → 304 (+22)
1.66% less ownership
Funds ownership: 107.58% → 105.92% (-1.7%)
Holders
304
Holding in Top 10
8
Calls
$295M
Puts
$140M
Top Buyers
| 1 | +$58.2M | |
| 2 | +$54.1M | |
| 3 | +$24.6M | |
| 4 |
Holocene Advisors
New York
|
+$24.6M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$23.9M |
Top Sellers
| 1 | -$101M | |
| 2 | -$79.5M | |
| 3 | -$68.7M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$40.7M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$36.2M |